SC Side Event to the 24th WIPO SCP, 29 June 2016
Title: Patents and Public Health: Exploring Options for Future Work in the WIPO
Date: 29 June 2016, 13:00-14:45
Venue: WIPO, Room B
Organizer: South Centre (more…)
Innovation
Research Paper 67, June 2016
Innovation and Global Intellectual Property Regulatory Regimes – The Tension between Protection and Access in Africa
This paper discusses the participation of African countries in global intellectual property (IP) regimes centred on the World Intellectual Property Organization (WIPO) and the World Trade Organization (WTO), and the implications of the expansion of the scope of IP regimes through bilateral trade and investment agreements. (more…)
Research Paper 61, March 2015
Guidelines on Patentability and Access to Medicines
Until recently, the link between the examination of patents carried out by national patent offices and the right of citizens to access to medicines was not at all clear. They were two functions or responsibilities of the State that apparently had nothing to do with each other. Examining the growing literature on intellectual property and access to medicines, it seems that the analysis of one actor has been left out: the patent offices. (more…)
Research Paper 58, December 2014
Patent Examination and Legal Fictions: How Rights are Created on Feet of Clay
Patents are often presented as an absolute property, comparable to property over land. This simplification overlooks that patent rights are conferred without a solid determination of the factual conditions required for such rights to arise out. The examination process of patent applications faces substantial limitations, even in the case of large patent offices, to determine whether a claimed invention actually meets the patentability standards, however defined. (more…)
Analytical Note, December 2014
Transition Period for Providing Patent Protection for Pharmaceutical Products by LDCs: The Need for Extension
How can Least Developed Countries (LDCs) make effective use of the transition period for the purposes stated in Article 66.1 of the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS), and in particular to promote access to affordable medicines and promote local manufacturing of generic medicines? Should LDCs seek a further extension of the transition period for pharmaceutical products beyond 1 January 2016?
Research Paper 54, September 2014
Innovative Financing Mechanisms: Potential Sources of Financing the WHO Tobacco Convention
- Introduction and Objectives
This research paper is produced as part of a research being conducted by the South Centre on expanding fiscal policies for global and national tobacco control. The objective of this research is to identify innovative solutions to fill the funding gaps in the implementation of the WHO Framework Convention on Tobacco Control (FCTC). (more…)
SouthViews No. 75, 8 August 2013
50 years of Development Planning in Africa: Retrospect and Prospects
By Carlos Lopes
A new era of development planning is emerging in Africa, says the new head of the UN Economic Commission for Africa, in this wide-ranging review. He gave this opening speech at the 50th anniversary conference of the African Institute for Economic Development and Planning (IDEP).
SouthViews No. 73, 26 June 2013
The man who saved millions with cheap medicines
By Martin Khor
His rivals called him a “pirate” but grateful millions whose lives were saved by his cheap generic medicines consider him a Robin Hood—Yusuf Hamied, leader of India’s giant company, Cipla.
SouthViews No. 38, 1 November 2012
Rethinking Regulation in Light of the Financial Crisis
By Yaga Venugopal Reddy
There is a recognition that policies relating to regulation of the financial sector must optimise the benefits of the financial sector while minimising the costs or risks associated with it. There are several dimensions to striking this balance, which this august audience is well aware of and involved with. I selected three themes for consideration today: the optimal level of financialisation, appropriate innovation in the financial sector, and the effectiveness of financial sector regulation.
SouthViews No. 33, 5 October 2012
South facing unfavourable global conditions; rethinking growth strategies is imperative
By Yilmaz Akyüz
The high-growth performance of many developing countries in 2003 to 2008 and then their quick recovery from the 2008-9 global financial crisis was largely due to favourable external conditions, including the policies in developed countries. (This was analysed in the previous issue of South Bulletin). However, these conditions do not exist today and in fact the global conditions have turned unfavourable. Hence developing countries are now facing serious vulnerabilities and risks to their economic situation, with each category of countries facing their own specific problems. Developing countries have to consider changing their growth and development strategies, in light of the changing global situation.
SouthViews No. 25, 26 July 2012
The Staggering Rise of the South?
By Yilmaz Akyüz
The theory that developing countries have de-coupled from growth in advanced economies and can continue with high growth even during the global slowdown is not based on proper examination of facts. A South Centre paper challenges the concept of the inexorable rise of the South. This is a summary of the arguments.
Research Paper 42, December 2011
Rethinking Global Health: A Binding Convention for R&D for Pharmaceutical Products.
This Research Paper is a contribution to the debate and reform process of the WHO to enable it to respond to the health and health policy challenges of the twenty-first century. More specifically, this paper addresses the issue of the pharmaceutical innovation system within the perspective of access to medicines, exploring possible structural changes in the current system. (more…)